Parabilis Medicines prices upsized IPO at $20 per share, raising $670 million above expected range
Posted On June 10, 2026
Parabilis’ successful IPO highlights strong investor confidence in biotech innovation, potentially accelerating advancements in oncology treatments.
The post Parabilis Medicines prices upsized IPO at $20 per share, raising $670 million above expected range appeared first on Crypto Briefing.
About The Author
